Natco Pharma launches generic drug with 180-day exclusivity in US
New Delhi, Aug 20 (PTI) Natco Pharma on Wednesday said it has launched a generic medication to treat high blood pressure in the lungs in the US with 180-day exclusivity.
The company has launched Bosentan tablets for oral suspension (32 mg), a generic version of Tracleer tablets by Actelion Pharmaceuticals US Inc.
Natco's marketing partner for the product is Lupin Ltd, the Hyderabad-based drug maker said in a regulatory filing.
Natco holds the first-to-file status for this product and will have 180-day generic drug exclusivity, it added.
The drug is indicated for the treatment of pulmonary arterial hypertension (PAH) in paediatric patients aged 3 years and older.
Bosentan tablets for oral suspension (32 mg) had estimated sales of USD 10 million in the US for 12 months ended June this year, as per industry sales data, Natco Pharma stated.
Shares of the drug firm were trading 0.53 per cent down at Rs 888.55 apiece on the BSE. PTI MSS MSS SHW
view comments
First Published:
August 20, 2025, 14:30 IST
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Loading comments...
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
20 minutes ago
- The Hindu
Natco Pharma launches generic drug for PAH in the U.S.
Natco Pharma has launched Bosentan tablets for oral suspension, 32mg, a generic version of Actelion Pharmaceuticals' Tracleer in the U.S. It holds the first-to-file status for this product and will have 180-day generic drug exclusivity, Natco said on Wednesday (August 20, 2025. Lupin is its marketing partner for the product. Bosentan TFOS, 32mg, had estimated sales of $10 million in the U.S. for 12 months ending June'25, the Hyderabad-based company said citing industry sales data. The drug is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in paediatric patients aged 3 years and older with idiopathic or congenital PAH to improve pulmonary vascular resistance, which is expected to result in an improvement in exercise ability.
Hindustan Times
an hour ago
- Hindustan Times
Shrimp, salad kits and more: See list of FDA food recalls in 2025 so far
The Food and Drug Administration (FDA) recently recalled frozen shrimp imported from an Indonesian firm over fears of Cesium-137 contamination, a radioactive isotope. The Guardian reported that the agency asked Walmart to pull three lots of Great Value brand frozen shrimp from its shelves. The frozen shrimp were recalled due to the presence of Cesium-137, a radioactive isotope.(Representatie image/Unsplash) Here is a look at other food products that were recalled this year so far. Also read: Novo Nordisk Shares Rise After FDA Approves Wegovy for Liver Disease Frozen shrimp The FDA issued an urgent recall of imported frozen shrimp sold at Walmart stores from PT. Bahari Makmur Sejati, an Indonesia-based firm. Since the products were prepared or held under 'insanitary conditions', the FDA fears they were contaminated by Cesium-137 (Cs-137). 'Consumers should not eat or serve certain lots of Great Value raw frozen shrimp sold at Walmart stores in AL, AR, FL, GA, KY, LA, MO, MS, OH, OK, PA, TX, and WV,' the FDA announced on its website. According to the agency, consumption of Cesium-137 can result in cancer. Frozen sprouted beans In July, the FDA reported that Chetak LLC Group recalled frozen sprouted beans over concerns about Salmonella infection and possible health risks. The FDA informed that Salmonella could cause fatal infection in people with a fragile immune system, including children and elderly people. Besides causing diarrhoea and abdominal pain, Salmonella can lead to arterial infections and arthritis, as per the FDA. The sprouted beans products that Chetak LLC Group recalled were Sprouted Mat (Moth) and Sprouted Moong. Also read: Grow a Garden: Full list of prickly plants and how to get them Sandwiches and snack items Fresh & Ready Foods, LLC, recalled a few of their ready-to-eat products, including sandwiches and other snack items, over fears of Listeria contamination in May this year. According to the Centers for Disease Control and Prevention (CDC), one person died and 10 people required hospitalization due to Listeria contamination in two states. The products that Fresh & Ready Foods, LLC, recalled included Fresh & Ready Foods Breakfast Bistro Box, Fresh & Ready Foods Protein Snack, Fresh & Ready Foods Italian Ciabatta Sandwich, Fresh & Ready Foods Ham & Cheese Croissant Sandwich, Fresh & Ready Foods Mike's Tuna Mac Pasta, and Fresh Take Crave Away Street Corn Dipper. Salad kits Little Leaf Farms announced a voluntary withdrawal of salad kits due to the potential presence of undeclared fish and wheat allergens, reported the FDA in March this year. After a consumer noticed the presence of incorrect ingredients in the brand's Southwest Salad Kit, Little Leaf Farms recalled the product. According to Little Leaf Farms, the allergens mentioned had the potential to cause life-threatening allergic reactions to people sensitive to wheat or fish. However, no injuries or illnesses were reported. FAQs Why did the FDA order a recall of frozen shrimp? The FDA ordered a recall of frozen shrimp over fears of Caesium-137 contamination. Were the shrimp products sold at Walmart? Yes, the shrimp products FDA has recalled were sold at Walmart. Which firm sold the shrimp products? Bahari Makmur Sejati, an Indonesian-based firm, sold the shrimp products.
News18
2 hours ago
- News18
'Still Struggles While Speaking, Pray For Him': Vinod Kambli's Brother Shares Concerning Update
Former India batter Vinod Kambli faces serious health and financial challenges. Despite treatment, he struggles with speech and mobility. His brother urges public prayers. Former India batter Vinod Kambli has been dealing with serious health challenges in recent times. Last year, he was seen at a public event with legendary Sachin Tendulkar, where he appeared to have difficulty walking. Shortly after, former India captain Sunil Gavaskar extended his support, assuring Kambli of the required assistance. With that help, Kambli underwent rehabilitation and also received medical treatment. However, his younger brother Virendra has now made a concerning revelation about his condition. Speaking on The Vickey Lalwani Show, Vinod Kambli's younger brother shared that the former cricketer is yet to fully recover from his health issues. Currently residing at his Bandra home, Kambli is undergoing recovery but continues to face challenges, particularly with his speech. 'He is at home right now. He is getting stable, but his treatment is on. He is having difficulty speaking. It will take him time to recover. But he is a champion, and he will come back. He will start walking and running, hopefully. I have a lot of faith in him. I hope you can see him back on the ground," said Virendra. 'He underwent rehab for 10 days. He had a comprehensive body check-up, including brain scans and a urine test. The results were fine; there weren't too many issues, but since he couldn't walk, he was advised to undergo physiotherapy. He still slurs in his speech, but he is getting better. I want to tell people who pray for him, so that he gets better. He needs your love and support," he added. Alongside his health struggles, Vinod Kambli is also facing financial difficulties. Earlier in January, his wife, Andrea Hewitt, disclosed that she had filed for divorce in 2023 but later withdrew it after witnessing her husband's 'helpless state'. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy. Loading comments...
